Cadila Pharmaceuticals launched Mycidac-C, a lung cancer drug

Dec 20, 2013, 12:36 IST

Mycidac-C, a new lung cancer drug was launched by Cadila Pharmaceuticals. The 10 course injection of the drug is priced 40000 rupees.

Cadila Pharmaceuticals on 21 November 2013 launched a new lung cancer drug, Mycidac-C, which is priced 40000 rupees for 10 course injection. The drug is much cheaper than the drugs manufactured by the multinational companies.

Cadila developed the drug after 15 years research and it will be available in Indian market from December 2013. Mycidac-C has been licensed and approved by the Drug Controller General of India (DCGI). The drug, Mycidac-C is meant for the patients, who suffer from non-small cell lung cancer (NSCLC).

If you have any Question/Point on the above information, please ask/discuss it in the Current Affairs Group

Jagranjosh
Jagranjosh

Education Desk

Your career begins here! At Jagranjosh.com, our vision is to enable the youth to make informed life decisions, and our mission is to create credible and actionable content that answers questions or solves problems for India’s share of Next Billion Users. As India’s leading education and career guidance platform, we connect the dots for students, guiding them through every step of their journey—from excelling in school exams, board exams, and entrance tests to securing competitive jobs and building essential skills for their profession. With our deep expertise in exams and education, along with accurate information, expert insights, and interactive tools, we bridge the gap between education and opportunity, empowering students to confidently achieve their goals.

... Read More
Get here latest daily, weekly and monthly Current Affairs and GK in English and Hindi for UPSC, SSC, Banking, Railway, Defence and exams. Download Jagran Josh Current Affairs App.

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

AndroidIOS

Trending

Latest Education News